Search for: "Cephalon Inc." Results 141 - 160 of 171
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
16 Nov 2008, 9:29 pm
The Federal Drug Administration (FDA) is now warning doctors about severe skin reactions in alcoholism patients who use Vivitrol, an injectable treatment made and marked by Cephalon, Inc. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
16 Oct 2008, 7:35 pm
This program is part of the Cephalon Speaker Series for Science and the Constitution, a partnership between Cephalon, Inc. and the National Constitution Center intended to attract local and national experts to discuss constitutional issues pertaining to science, public policy and the law. [read post]
6 Oct 2008, 3:54 pm
In a serious case of products liability, drug maker Cephalon, Inc. will pay $425 million in a settlement for illegally marketing a highly addictive lollipop painkiller and two other pharmaceuticals for non-approved uses. [read post]
2 Oct 2008, 10:18 pm
Drug maker Cephalon Inc. will pay $431 million to settle a number of whistleblower lawsuits accusing the company of promoting drugs for unapproved uses. [read post]
13 Aug 2008, 6:46 pm
The FDA is warning doctors about severe skin reactions in alcoholism patients who use Vivitrol, an injectable treatment made and marketed by Cephalon Inc. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
1 Jul 2008, 4:31 am
In previous reports, we noted that a handful of biotech/pharma companies spent significant amounts of money lobbying the federal government in the first quarter of 2008, including: • Abbott Laboratories -- $880,000 • Amgen Inc. -- $2.5 million • Cephalon,... [read post]
13 Jun 2008, 3:40 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
7 Jun 2008, 3:34 am
Included on our list were Cephalon, Inc., which spent $512,000, Abbott Laboratories, which spent $880,000, and Amgen Inc., which spent $2.5 million. [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
27 Apr 2008, 7:35 pm
The Cephalon Speaker Series for Science and the Constitution is a partnership between Cephalon, Inc. and the National Constitution Center intended to attract local and national experts to discuss constitutional issues pertaining to science, public policy and the law. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
15 Jan 2008, 6:35 pm
The Cephalon Speaker Series for Science and the Constitution is a partnership between Cephalon, Inc. and the National Constitution Center intended to attract local and national experts to discuss constitutional issues pertaining to science, public policy and the law. [read post]